Elmezogi Jamal, Ben Hussien Gazala, Erhuma Mabrouk, Gadmour Manal, Zetrini Abdulmotaleb, Abdolgader Abossa, Jamil Ahmad Shilpi


Three Libyan plants namely Ballota pseudodictamnus, Hedera helix, Thapsia garganica were tested for anticancer activity. The plants, collected from Aljabal-Al-Akhdar area of Libya in April 2010 were shed dried and subjected to Soxhlet extraction by methanol. Phytochemical screening indicated the presence of 2-deoxy sugars, flavonoids, saponins and tannins but absence of alkaloids in all three plants under investigation. Antiproliferative activity was performed breast adenocarcinoma cell line (MCF7). At the concentration of 100µg/mL, B. pseudodictamnus, T. garganica and H. helix showed 90, 60 and 5% cell death, respectively as compared to the control.

Key words: Antiproliferative; Breast adenocarcinoma; Cell l ine MCF-7

Full Text:

PDF (127-130)


Bauer BA., 2000, Herbal therapy: what a clinician needs to know to counsel patients effectively. Mayo Clinic Proceedings. 7:835-841.

Cardellina JH., Fuller RW., Gamble WR., Westergaard C., Boswell J., Munro MHG., Currens M., and Boyd MP., 1999, Evolving strategies for the selection dereplication and prioritization of antitumor and HIV inhibitory natural products extracts. In: Bohlin L, Bruhn JG (Eds), Bioassay Methods in Natural Product Research and Development. Kluwer Academic Publishers, Dordrecht. pp. 25-36.

Chin YW., Balunas MJ., Chai HB., and Kinghorn AD., 2006, Drug Discovery from Natural Sources, The AAPS J..8:E239-E253.

Citoglu GS., Coban T., Sever B., and Iscan M., 2004, Antioxidant properties of Ballota

species growing in Turkey, Journal of Ethnopharmacol, 92:275-80. Coleman, W.B., Tsongalis, G.J., 2002, The Molecular basis of human cancer, Humana Press Inc., Totowa, NJ. pp. 347-363.

Couladis M., Chinou IB., Tzakou O., and Loukis A., 2002, Composition and antimicrobial activity of the essential oil of Ballota pseudodictamnus L. Bentham, Phytotherapy Research. 16:723-726.

Cowan MM., 1999, Plants products as antimicrobial agents, Clin. Microbiology Review. 12:564-582.

Crown J., Diéras V., Kaufmann M., von Minckwitz G., Kaye S., Leonard R., Marty M., Misset JL., Osterwalder B., and Piccart M., 2002, Chemotherapy for metastatic breast cancer-report of a

European expert panel, Lancet Oncology. 3:719-726.

Elias R., De Méo M., Vidal-Ollivier E., Laget M., Balansard G., and Dumenil G., 1990, Antimutagenic activity of some saponins isolated from Calendula officinalis L., C.

arvensis L. and Hedera helix L.Mutagenesis. 5:327-331.

Harborne JB., 1998, Phytochemical methods, a guide to modern techniques of plant analysis, Chapman and Hall, London.

Jemal A., Bray F., Center MM., Ferlay J., Ward E., Forman D., 2011, Global Cancer

Statistics, Cancer J. for Clini. 61:69–90.

Ikhiri K., Boureima D., and Dan-Kouloudo D., 1992, Chemical screening of medicinal

plants used in traditional pharmacopoeia of Niger, Int. J.Pharmacognosy. 30:251-262.

Liu H., Jensen KG., Tran LM., Chen M., Zhai L., Olsen CE., Søhoel H., Denmeade

SR., Isaacs JT., and Christensen SB., 2006, Cytotoxic phenylpropanoids and an additional thapsigargin analogue isolated from Thapsia garganica, Phytochemistry, 67:2651-2658.

Madhuri S. and Pandey, G., 2009, Some anticancer medicinal plants of foreign origin, Current Science, 96:779-783.

Mandade RJ., Choudhuri A., Mashirkar V., and Sakarkar D., 2010, Analgesic and antiinflammatory activities of Hedera helix leaf extract, Pharmacie Globale (Int. J.

Comp. Phar.), 4:1-3.

Reddy L., Odhav B., and Bhoola KD., 2003, Natural products for cancer prevention: a global perspective, Pharmacology & Therapeutics, 99:1-13.

Robinson KM., Haffejee AA., and Angorn, I.B., 1980, Tissue culture and prognosis in carcinoma of the oesophagus, Clinical Oncology, 6:125-136.



  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indonesian J Pharm indexed by:

analytics View My Stats